BERKELEY
HEIGHTS, N.J., April 23,
2024 /PRNewswire/ -- Axtria, Inc., a global
leader of award-winning cloud software and an integrated analytics
solutions provider with deep experience in real-world evidence
(RWE) and health economics and outcomes research (HEOR), will
present at ISPOR 2024.
The Professional Society for Health Economics and Outcomes
Research (ISPOR) will hold its ISPOR 2024 conference on May 5–8,
2024 in Atlanta, GA. The
conference will unite industry and academic researchers,
policymakers, regulators, payers, patient representatives, and
other healthcare stakeholders to explore the latest issues in RWE
and HEOR.
Axtria's David Hood,
Senior Manager, RWE and HEOR, will present "Patients' Perspectives
on Muscular Dystrophy: Insights from Social Media Listening." In
addition, Coby Martin,
Project Leader, HEOR and Evidence Synthesis, will present
"Targeted Literature Review of the Use of Real-World Evidence from
Single Real-World Data and Sources in Meta-Analyses: Methodologies
and Recommendations from HTA Bodies."
"We eagerly anticipate sharing our pioneering insights and
strategies in real-world evidence and health economics outcomes
research," said Won Chan Lee,
Ph.D., Principal, Practice Lead of RWE, HEOR, and Evidence
Synthesis Practice at Axtria. "As a leader in this field, Axtria is
committed to advancing healthcare through innovation and
collaboration, and we look forward to engaging with peers and
industry experts at this prestigious event."
Axtria will also present nine posters at ISPOR 2024. For
more information on Axtria's RWE, HEOR & Evidence Synthesis
practice, and poster presentations, please visit the following
links:
- Axtria RWE, HEOR & Evidence Synthesis
- Anhedonia-Related Wording in Social Media: An Application of
Natural Language Processing
- Use of External Control Arms in Novel Drug Approvals by U.S.
Food and Drug Administration: A Targeted Review
- Predictive Horizons: Unveiling Cardiovascular Insights with
Conditional Inference Trees
- Comparing Predictive Models: Traditional vs. Modern Statistical
Approaches for Economic Outcomes in Major Depressive Disorder
- A Cost-Effectiveness Analysis of Intrauterine Spacers Used to
Prevent the Formation of Intrauterine Adhesions Following
Endometrial Cavity Surgery
- An updated landscape of FDA-approved Artificial Intelligence
and Machine Learning (AI/ML)-Enabled Medical Devices from
1995-2023
- The Use of Natural Language Processing in Literature
Reviews
- Novel Drug Approvals By the U.S. Food and Drug Administration
in Rare Diseases: Findings from 2020–2023
- Burden of Illness of Intrauterine Adhesions Following
Intrauterine Procedures: A Retrospective Analysis of Real-World
Data
Meet our RWE and HEOR experts at Booth 407. Please click here to
schedule a meeting with Axtria's team at ISPOR 2024 and/or to learn
more about our RWE and HEOR analytics solutions.
About Axtria's Products and Solutions
Axtria is proud to work with 16 of the top 20 life sciences
companies, globally. From our roots as a trusted consultant to our
status as one of the world's leading providers of cloud-based
pharmaceutical management software, Axtria has been powering the
digital transformation of life sciences. Our experts call upon
years of domain experience in the industry to guide pharma giants
from brand launches to retirement. Our products go even further.
Axtria InsightsMAx™ helps everyone from the C-suite to junior
associates uncover trends to make better decisions. Axtria SalesIQ™
helps optimize field forces and provider engagements. Axtria
CustomerIQ™ leverages AI-enabled next-best-action omnichannel
choices. Axtria MarketingIQ™ turns investment analyses into
pinpoint strategies. And Axtria DataMAx™ and DataMAx™ for Emerging
Pharma is the data management framework that pulls it all together
with best-in-class security and integration.
About Axtria
Axtria is a leading global provider of award-winning cloud
software and data analytics to the life sciences industry. We focus
on improving healthcare outcomes for patients. We're proud to
deliver proven solutions that help pharmaceutical, medical device,
and diagnostics companies complete their journey from data to
insights to action, enabling them to earn superior returns on their
investments. As a participant in the United Nations Global Compact,
Axtria is committed to aligning strategies and operations with
universal principles on human rights, labor, environment, and
anti-corruption, and taking actions that advance societal goals.
For more information, please visit www.axtria.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/rwe-heor-and-evidence-synthesis-practice-at-axtria-to-present-at-ispor-2024-conference-302124325.html
SOURCE Axtria, Inc.